Tag: ACCESS 2

Vascular Therapies completes enrolment in the ACCESS 2 study

Vascular Therapies has today announced completion of enrolment in the ACCESS 2 trial, a Phase III prospective randomised, multicentre clinical study of SirogenĀ for the...